NEW YORK (GenomeWeb) – Abbott and Alere said today that they have agreed to amend the terms of their acquisition agreement and dismiss lawsuits they had filed against each other.

Under the amended terms, Abbott will pay $51 per share to acquire Alere for a new total price of about  $5.3 billion — reduced from an original purchase price of around $5.8 billion proposed in February 2016 when Abbott announced that it was acquiring Alere.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.

The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.

The New York Times writes that natural history museums are helping round out genetic studies with older specimens.

In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.